| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.912 | 0.001 | 0.912 | 5 Hydroxytryptamine release stimulant | 0.896 0.002 CID_15897 | ||
| 0.728 | 0.009 | 0.728 | Antiobesity | 0.512 0.035 CID_15897 | ||
| 0.579 | 0.003 | 0.617 | 5 Hydroxytryptamine uptake stimulant | 0.617 0.003 CID_15897 | CID_15897 | |
| 0.565 | 0.007 | 0.565 | Psychostimulant | 0.494 0.011 CID_15897 | ||
| 0.494 | 0.016 | 0.494 | Cardiotonic | |||
| 0.456 | 0.022 | 0.456 | Vasodilator, coronary | 0.281 0.104 CID_15897 | ||
| 0.467 | 0.059 | 0.572 | Analgesic | 0.572 0.032 CID_15897 | CID_15897 | |
| 0.445 | 0.041 | 0.445 | Cholesterol antagonist | 0.362 0.059 CID_15897 | ||
| 0.46 | 0.063 | 0.46 | Cyclophilin D inhibitor | 0.357 0.117 CID_15897 | ||
| 0.424 | 0.064 | 0.537 | 5 Hydroxytryptamine release inhibitor | 0.537 0.022 CID_15897 | CID_15897 | |
| 0.331 | 0.007 | 0.331 | Nav1.3 sodium channel blocker | 0.143 0.053 CID_15897 | ||
| 0.368 | 0.047 | 0.368 | Spasmolytic | 0.226 0.102 CID_15897 | ||
| 0.337 | 0.019 | 0.409 | Tyrosine 3 hydroxylase inhibitor | 0.409 0.007 CID_15897 | CID_15897 | |
| 0.408 | 0.094 | 0.451 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.451 0.06 CID_15897 | CID_15897 | |
| 0.381 | 0.071 | 0.381 | Calpain 2 inhibitor | 0.264 0.139 CID_15897 | ||
| 0.289 | 0.016 | 0.289 | Nav1.2 sodium channel blocker | 0.229 0.026 CID_15897 | ||
| 0.372 | 0.101 | 0.404 | Calcium channel L-type activator | 0.404 0.079 CID_15897 | CID_15897 | |
| 0.309 | 0.047 | 0.46 | Superoxide dismutase inhibitor | 0.46 0.017 CID_15897 | CID_15897 | |
| 0.313 | 0.051 | 0.354 | Insulysin inhibitor | 0.354 0.033 CID_15897 | CID_15897 | |
| 0.286 | 0.026 | 0.286 | Neuropeptide Y2 antagonist | 0.283 0.028 CID_15897 | ||
| 0.263 | 0.007 | 0.263 | Calcium channel N-type blocker | 0.191 0.019 CID_15897 | ||
| 0.292 | 0.038 | 0.292 | Gastrin inhibitor | 0.204 0.143 CID_15897 | ||
| 0.284 | 0.038 | 0.284 | Calpain inhibitor | 0.258 0.057 CID_15897 | ||
| 0.374 | 0.128 | 0.402 | Caspase 9 stimulant | 0.402 0.11 CID_15897 | CID_15897 | |
| 0.253 | 0.016 | 0.253 | Calcium channel blocker | 0.149 0.059 CID_15897 | ||
| 0.246 | 0.01 | 0.246 | Nav1.6 sodium channel blocker | 0.195 0.021 CID_15897 | ||
| 0.244 | 0.013 | 0.244 | Bronchodilator | |||
| 0.279 | 0.059 | 0.315 | Antiamyloidogenic | 0.315 0.047 CID_15897 | CID_15897 | |
| 0.239 | 0.022 | 0.239 | 5 Hydroxytryptamine 3E antagonist | 0.215 0.042 CID_15897 | ||
| 0.223 | 0.013 | 0.223 | Calcium channel (voltage-sensitive) blocker | 0.136 0.042 CID_15897 | ||
| 0.232 | 0.024 | 0.232 | Anesthetic local | 0.107 0.077 CID_15897 | ||
| 0.213 | 0.014 | 0.213 | Ca(v)2.2 blocker | 0.192 0.018 CID_15897 | ||
| 0.237 | 0.042 | 0.266 | Insulin sensitizer | 0.266 0.026 CID_15897 | CID_15897 | |
| 0.206 | 0.013 | 0.206 | Calcium antagonist | 0.082 0.062 CID_15897 | ||
| 0.217 | 0.034 | 0.218 | Thiol protease inhibitor | 0.218 0.034 CID_15897 | CID_15897 | |
| 0.204 | 0.025 | 0.204 | Adenylate cyclase inhibitor | 0.189 0.028 CID_15897 | ||
| 0.247 | 0.068 | 0.247 | Hypolipemic | 0.151 0.135 CID_15897 | ||
| 0.201 | 0.024 | 0.201 | Antiadrenergic | |||
| 0.194 | 0.025 | 0.194 | Adrenaline antagonist | |||
| 0.175 | 0.01 | 0.175 | Adrenaline agonist | 0.101 0.036 CID_15897 | ||
| 0.187 | 0.022 | 0.187 | Nav1.1 sodium channel blocker | 0.104 0.061 CID_15897 | ||
| 0.24 | 0.075 | 0.24 | Vasodilator | |||
| 0.284 | 0.121 | 0.284 | Toll-Like receptor 7 agonist | |||
| 0.178 | 0.015 | 0.178 | Sphingomyelinase inhibitor | 0.122 0.04 CID_15897 | ||
| 0.281 | 0.123 | 0.281 | Toll-Like receptor agonist | |||
| 0.269 | 0.114 | 0.378 | Transcription factor NF kappa B inhibitor | 0.378 0.069 CID_15897 | CID_15897 | |
| 0.223 | 0.068 | 0.223 | Anticonvulsant | 0.195 0.086 CID_15897 | ||
| 0.198 | 0.05 | 0.221 | Antipruritic | 0.221 0.036 CID_15897 | CID_15897 | |
| 0.168 | 0.022 | 0.188 | Sphingosine 1-phosphate receptor 2 antagonist | 0.188 0.011 CID_15897 | CID_15897 | |
| 0.248 | 0.104 | 0.248 | Ca(v)3.3 blocker | 0.246 0.107 CID_15897 | ||
| 0.269 | 0.125 | 0.302 | Calcium channel activator | 0.302 0.09 CID_15897 | CID_15897 | |
| 0.183 | 0.047 | 0.193 | Neurotensin receptor agonist | 0.193 0.039 CID_15897 | CID_15897 | |
| 0.17 | 0.035 | 0.17 | Adenylate cyclase stimulant | 0.163 0.044 CID_15897 | ||
| 0.136 | 0.006 | 0.167 | Neurokinin antagonist | 0.167 0.005 CID_15897 | CID_15897 | |
| 0.149 | 0.023 | 0.195 | Nitric-oxide synthase inhibitor | 0.195 0.01 CID_15897 | CID_15897 | |
| 0.131 | 0.006 | 0.237 | 5 Hydroxytryptamine 2 agonist | 0.237 0.004 CID_15897 | CID_15897 | |
| 0.164 | 0.039 | 0.164 | Proteasome inhibitor | 0.148 0.047 CID_15897 | ||
| 0.129 | 0.005 | 0.163 | Neurokinin 1 antagonist | 0.163 0.005 CID_15897 | CID_15897 | |
| 0.2 | 0.077 | 0.286 | Neurotrophic factor enhancer | 0.286 0.022 CID_15897 | CID_15897 | |
| 0.136 | 0.014 | 0.136 | Glutamate release inhibitor | 0.13 0.016 CID_15897 | ||
| 0.127 | 0.005 | 0.159 | Substance P antagonist | 0.159 0.005 CID_15897 | CID_15897 | |
| 0.182 | 0.061 | 0.188 | Thrombolytic | 0.188 0.058 CID_15897 | CID_15897 | |
| 0.127 | 0.008 | 0.315 | 5 Hydroxytryptamine 2A agonist | 0.315 0.003 CID_15897 | CID_15897 | |
| 0.131 | 0.013 | 0.131 | Calcium channel L-type blocker | 0.086 0.034 CID_15897 | ||
| 0.12 | 0.005 | 0.12 | Sigma 1 receptor antagonist | |||
| 0.128 | 0.014 | 0.161 | Sphingosine 1-phosphate receptor 4 agonist | 0.161 0.007 CID_15897 | CID_15897 | |
| 0.15 | 0.038 | 0.215 | Aminopeptidase B inhibitor | 0.215 0.018 CID_15897 | CID_15897 | |
| 0.144 | 0.033 | 0.146 | GABA C receptor antagonist | 0.146 0.032 CID_15897 | CID_15897 | |
| 0.16 | 0.05 | 0.18 | Alpha-N-acetylglucosaminidase inhibitor | 0.18 0.041 CID_15897 | CID_15897 | |
| 0.119 | 0.01 | 0.119 | Beta 3 adrenoreceptor antagonist | |||
| 0.231 | 0.124 | 0.231 | Nootropic | |||
| 0.151 | 0.046 | 0.199 | Cathepsin H inhibitor | 0.199 0.023 CID_15897 | CID_15897 | |
| 0.197 | 0.094 | 0.226 | Nitric-oxide synthase stimulant | 0.226 0.053 CID_15897 | CID_15897 | |
| 0.137 | 0.036 | 0.139 | Nav1.5 sodium channel blocker | 0.139 0.035 CID_15897 | CID_15897 | |
| 0.158 | 0.057 | 0.184 | Cytokine production inhibitor | 0.184 0.042 CID_15897 | CID_15897 | |
| 0.17 | 0.071 | 0.17 | ATPase inhibitor | 0.166 0.076 CID_15897 | ||
| 0.098 | 0.002 | 0.098 | Histamine H1 receptor agonist | 0.086 0.003 CID_15897 | ||
| 0.109 | 0.014 | 0.121 | Secretase beta inhibitor | 0.121 0.01 CID_15897 | CID_15897 | |
| 0.115 | 0.021 | 0.166 | Aminopeptidase I inhibitor | 0.166 0.01 CID_15897 | CID_15897 | |
| 0.105 | 0.015 | 0.105 | Beta adrenoreceptor antagonist | |||
| 0.149 | 0.063 | 0.205 | Sphingosine 1-phosphate receptor 5 antagonist | 0.205 0.009 CID_15897 | CID_15897 | |
| 0.105 | 0.019 | 0.105 | Estrogen-related receptor beta agonist | 0.093 0.035 CID_15897 | ||
| 0.113 | 0.028 | 0.163 | Inducible nitric-oxide synthase inhibitor | 0.163 0.013 CID_15897 | CID_15897 | |
| 0.133 | 0.049 | 0.162 | 5 Hydroxytryptamine 2B antagonist | 0.162 0.036 CID_15897 | CID_15897 | |
| 0.229 | 0.145 | 0.229 | Vasodilator, peripheral | 0.194 0.184 CID_15897 | ||
| 0.092 | 0.009 | 0.092 | Epithelial sodium channel blocker | 0.088 0.01 CID_15897 | ||
| 0.173 | 0.092 | 0.24 | Anesthetic general | 0.24 0.055 CID_15897 | CID_15897 | |
| 0.125 | 0.044 | 0.125 | Protease inhibitor | 0.125 0.044 CID_15897 | ||
| 0.143 | 0.063 | 0.166 | Sodium channel blocker | 0.166 0.047 CID_15897 | CID_15897 | |
| 0.086 | 0.006 | 0.086 | Beta 2 adrenoreceptor agonist | 0.071 0.018 CID_15897 | ||
| 0.115 | 0.035 | 0.115 | ABCA1 expression enhancer | 0.085 0.076 CID_15897 | ||
| 0.135 | 0.057 | 0.162 | Vanilloid 1 agonist | 0.162 0.028 CID_15897 | CID_15897 | |
| 0.119 | 0.041 | 0.151 | Creatine kinase inhibitor | 0.151 0.024 CID_15897 | CID_15897 | |
| 0.142 | 0.066 | 0.159 | Ca2+-transporting ATPase inhibitor | 0.159 0.025 CID_15897 | CID_15897 | |
| 0.091 | 0.015 | 0.091 | Potassium channel (Tandem pore domain) blocker | 0.086 0.022 CID_15897 | ||
| 0.131 | 0.057 | 0.131 | Acetylcholine muscarinic antagonist | |||
| 0.09 | 0.015 | 0.09 | Bombesin 2 receptor antagonist | 0.074 0.018 CID_15897 | ||
| 0.146 | 0.072 | 0.146 | Neuropeptide Y1 antagonist | 0.137 0.086 CID_15897 | ||
| 0.116 | 0.043 | 0.12 | Factor V inhibitor | 0.12 0.039 CID_15897 | CID_15897 | |
| 0.086 | 0.014 | 0.086 | Beta 1 adrenoreceptor antagonist | |||
| 0.108 | 0.036 | 0.121 | Ornithine decarboxylase inhibitor | 0.121 0.025 CID_15897 | CID_15897 | |
| 0.084 | 0.013 | 0.111 | Neurokinin 2 antagonist | 0.111 0.009 CID_15897 | CID_15897 | |
| 0.102 | 0.032 | 0.102 | Myeloperoxidase inhibitor | 0.1 0.035 CID_15897 | ||
| 0.084 | 0.014 | 0.085 | Corticotropin releasing factor 2 receptor antagonist | 0.085 0.013 CID_15897 | CID_15897 | |
| 0.09 | 0.02 | 0.108 | Protease 3C (Human rhinovirus) inhibitor | 0.108 0.013 CID_15897 | CID_15897 | |
| 0.08 | 0.012 | 0.08 | Beta 2 adrenoreceptor antagonist | |||
| 0.08 | 0.014 | 0.08 | Histamine agonist | 0.067 0.021 CID_15897 | ||
| 0.107 | 0.042 | 0.137 | 5 Hydroxytryptamine 2C antagonist | 0.137 0.03 CID_15897 | CID_15897 | |
| 0.082 | 0.017 | 0.182 | Glycine transporter 2 inhibitor | 0.182 0.006 CID_15897 | CID_15897 | |
| 0.103 | 0.038 | 0.194 | Catalase inhibitor | 0.194 0.016 CID_15897 | CID_15897 | |
| 0.071 | 0.006 | 0.175 | 5 Hydroxytryptamine 2B agonist | 0.175 0.003 CID_15897 | CID_15897 | |
| 0.097 | 0.033 | 0.4 | 5 Hydroxytryptamine 1F antagonist | 0.4 0.005 CID_15897 | CID_15897 | |
| 0.106 | 0.044 | 0.114 | Opioid antagonist | 0.114 0.039 CID_15897 | CID_15897 | |
| 0.087 | 0.025 | 0.087 | Phospholipase D inhibitor | 0.066 0.062 CID_15897 | ||
| 0.131 | 0.069 | 0.173 | MAO inhibitor | 0.173 0.05 CID_15897 | CID_15897 | |
| 0.083 | 0.022 | 0.119 | Exportin-1 inhibitor | 0.119 0.005 CID_15897 | CID_15897 | |
| 0.091 | 0.031 | 0.091 | Epoxide hydrolase inhibitor | 0.068 0.056 CID_15897 | ||
| 0.071 | 0.012 | 0.075 | Adenylate cyclase 1 inhibitor | 0.075 0.01 CID_15897 | CID_15897 | |
| 0.112 | 0.053 | 0.123 | Carbonic anhydrase XV inhibitor | 0.123 0.045 CID_15897 | CID_15897 | |
| 0.103 | 0.045 | 0.103 | Potassium channel activator | 0.089 0.062 CID_15897 | ||
| 0.128 | 0.07 | 0.171 | Toll-Like receptor 2 antagonist | 0.171 0.039 CID_15897 | CID_15897 | |
| 0.076 | 0.018 | 0.146 | Sphingosine kinase 2 inhibitor | 0.146 0.004 CID_15897 | CID_15897 | |
| 0.076 | 0.018 | 0.076 | Heme oxygenase stimulant | 0.061 0.042 CID_15897 | ||
| 0.106 | 0.049 | 0.106 | Prolactin inhibitor | 0.106 0.049 CID_15897 | ||
| 0.095 | 0.038 | 0.205 | CYP2A6 inhibitor | 0.205 0.007 CID_15897 | CID_15897 | |
| 0.174 | 0.118 | 0.174 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.077 | 0.021 | 0.077 | Sigma receptor antagonist | |||
| 0.068 | 0.012 | 0.068 | Gonadotropin-releasing hormone receptor antagonist | |||
| 0.08 | 0.025 | 0.08 | TRPA1 antagonist | 0.079 0.026 CID_15897 | ||
| 0.105 | 0.05 | 0.11 | Glutamate (mGluR7) agonist | 0.11 0.043 CID_15897 | CID_15897 | |
| 0.075 | 0.021 | 0.093 | Potassium channel intermediate-conductance Ca-activated blocker | 0.093 0.011 CID_15897 | CID_15897 | |
| 0.062 | 0.008 | 0.062 | Potassium channel Kv1.1 blocker | 0.06 0.009 CID_15897 | ||
| 0.112 | 0.059 | 0.112 | Interleukin 2 antagonist | 0.105 0.076 CID_15897 | ||
| 0.09 | 0.037 | 0.09 | Ca(v)3.1 blocker | |||
| 0.067 | 0.016 | 0.076 | Lysophosphatidic acid 3 receptor antagonist | 0.076 0.011 CID_15897 | CID_15897 | |
| 0.059 | 0.008 | 0.059 | Beta adrenoreceptor agonist | 0.045 0.031 CID_15897 | ||
| 0.08 | 0.029 | 0.092 | NMDA receptor agonist | 0.092 0.022 CID_15897 | CID_15897 | |
| 0.089 | 0.039 | 0.089 | CC chemokine 5 receptor agonist | 0.086 0.046 CID_15897 | ||
| 0.136 | 0.086 | 0.168 | Hemostatic | 0.168 0.05 CID_15897 | CID_15897 | |
| 0.072 | 0.023 | 0.093 | Sphingosine 1-phosphate receptor 3 antagonist | 0.093 0.01 CID_15897 | CID_15897 | |
| 0.083 | 0.035 | 0.167 | Phenylalanine 4-hydroxylase inhibitor | 0.167 0.009 CID_15897 | CID_15897 | |
| 0.071 | 0.022 | 0.071 | Protease activated receptor 1 antagonist | 0.057 0.029 CID_15897 | ||
| 0.089 | 0.041 | 0.089 | Vanilloid antagonist | |||
| 0.073 | 0.028 | 0.075 | Cathepsin L inhibitor | 0.075 0.027 CID_15897 | CID_15897 | |
| 0.066 | 0.02 | 0.085 | Dipeptidyl peptidase inhibitor | 0.085 0.012 CID_15897 | CID_15897 | |
| 0.062 | 0.018 | 0.062 | Potassium channel (Inward rectifier) activator | 0.059 0.021 CID_15897 | ||
| 0.134 | 0.091 | 0.134 | Acetylcholine M1 receptor antagonist | 0.126 0.101 CID_15897 | ||
| 0.068 | 0.026 | 0.068 | CC chemokine 2 receptor antagonist | 0.058 0.034 CID_15897 | ||
| 0.059 | 0.017 | 0.059 | Potassium channel (ATP-sensitive) activator | 0.056 0.02 CID_15897 | ||
| 0.061 | 0.019 | 0.065 | Neurokinin 3 antagonist | 0.065 0.016 CID_15897 | CID_15897 | |
| 0.065 | 0.023 | 0.065 | Myc inhibitor | |||
| 0.135 | 0.094 | 0.164 | Heat shock protein 70 antagonist | 0.164 0.023 CID_15897 | CID_15897 | |
| 0.213 | 0.171 | 0.213 | Sodium/bile acid cotransporter inhibitor | |||
| 0.055 | 0.014 | 0.081 | TRPM8 blocker | 0.081 0.008 CID_15897 | CID_15897 | |
| 0.07 | 0.029 | 0.07 | Cathepsin D inhibitor | 0.059 0.035 CID_15897 | ||
| 0.071 | 0.03 | 0.071 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.08 | 0.04 | 0.093 | Opioid mu receptor antagonist | 0.093 0.034 CID_15897 | CID_15897 | |
| 0.117 | 0.077 | 0.117 | Cholinergic antagonist | |||
| 0.093 | 0.054 | 0.097 | Aminoacyl-tRNA synthetase inhibitor | 0.097 0.048 CID_15897 | CID_15897 | |
| 0.053 | 0.015 | 0.114 | Kinesin-like protein 1 inhibitor | 0.114 0.006 CID_15897 | CID_15897 | |
| 0.053 | 0.015 | 0.114 | Kinesin antagonist | 0.114 0.006 CID_15897 | CID_15897 | |
| 0.057 | 0.019 | 0.057 | Oxytocin agonist | 0.057 0.019 CID_15897 | ||
| 0.137 | 0.099 | 0.279 | Growth hormone agonist | 0.279 0.037 CID_15897 | CID_15897 | |
| 0.133 | 0.096 | 0.172 | Phospholipase A2 inhibitor | 0.172 0.058 CID_15897 | CID_15897 | |
| 0.134 | 0.097 | 0.134 | GABA C receptor rho-2 antagonist | |||
| 0.055 | 0.018 | 0.065 | Histamine H2 receptor agonist | 0.065 0.012 CID_15897 | CID_15897 | |
| 0.045 | 0.009 | 0.073 | Tryptophan 5 hydroxylase inhibitor | 0.073 0.003 CID_15897 | CID_15897 | |
| 0.054 | 0.018 | 0.056 | Cathepsin L1 inhibitor | 0.056 0.017 CID_15897 | CID_15897 | |
| 0.113 | 0.077 | 0.113 | Acetylcholine antagonist | |||
| 0.12 | 0.084 | 0.166 | Sodium channel (voltage-gated) blocker | 0.166 0.044 CID_15897 | CID_15897 | |
| 0.061 | 0.026 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | 0.061 0.026 CID_15897 | ||
| 0.049 | 0.014 | 0.049 | Cathepsin F inhibitor | 0.043 0.024 CID_15897 | ||
| 0.049 | 0.015 | 0.058 | Diamine oxidase inhibitor | 0.058 0.01 CID_15897 | CID_15897 | |
| 0.044 | 0.01 | 0.044 | Cholesterol ester transfer protein antagonist | 0.042 0.011 CID_15897 | ||
| 0.051 | 0.017 | 0.051 | Plasmepsin II inhibitor | 0.042 0.027 CID_15897 | ||
| 0.044 | 0.01 | 0.044 | Lysophosphatidic acid 2 receptor antagonist | 0.04 0.012 CID_15897 | ||
| 0.067 | 0.034 | 0.067 | Acetylcholine M3 receptor antagonist | |||
| 0.052 | 0.019 | 0.052 | Acetyl-CoA carboxylase inhibitor | |||
| 0.064 | 0.031 | 0.064 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.051 | 0.019 | 0.067 | Dipeptidyl peptidase IV inhibitor | 0.067 0.01 CID_15897 | CID_15897 | |
| 0.037 | 0.005 | 0.037 | Protease (Human cytomegalovirus) inhibitor | 0.036 0.005 CID_15897 | ||
| 0.098 | 0.066 | 0.098 | GABA C receptor rho-1 antagonist | 0.09 0.078 CID_15897 | ||
| 0.11 | 0.079 | 0.13 | Transcription factor STAT6 inhibitor | 0.13 0.044 CID_15897 | CID_15897 | |
| 0.063 | 0.033 | 0.063 | Cathepsin B inhibitor | 0.056 0.039 CID_15897 | ||
| 0.035 | 0.005 | 0.035 | Acid ceramidase inhibitor | 0.027 0.015 CID_15897 | ||
| 0.07 | 0.04 | 0.117 | Opioid delta receptor antagonist | 0.117 0.026 CID_15897 | CID_15897 | |
| 0.063 | 0.034 | 0.116 | Sphingosine kinase inhibitor | 0.116 0.005 CID_15897 | CID_15897 | |
| 0.078 | 0.049 | 0.094 | Sphingosine 1-phosphate receptor antagonist | 0.094 0.026 CID_15897 | CID_15897 | |
| 0.173 | 0.145 | 0.265 | Interleukin agonist | 0.265 0.068 CID_15897 | CID_15897 | |
| 0.059 | 0.031 | 0.078 | Sphingosine 1-phosphate receptor 1 antagonist | 0.078 0.014 CID_15897 | CID_15897 | |
| 0.034 | 0.007 | 0.08 | Glutamate (mGluR1) agonist | 0.08 0.004 CID_15897 | CID_15897 | |
| 0.079 | 0.053 | 0.125 | Somatostatin 1 agonist | 0.125 0.021 CID_15897 | CID_15897 | |
| 0.098 | 0.072 | 0.12 | Falcipain 3 inhibitor | 0.12 0.053 CID_15897 | CID_15897 | |
| 0.049 | 0.023 | 0.058 | Cathepsin L2 inhibitor | 0.058 0.019 CID_15897 | CID_15897 | |
| 0.064 | 0.038 | 0.064 | Histone deacetylase SIRT3 inhibitor | 0.064 0.037 CID_15897 | ||
| 0.03 | 0.005 | 0.03 | Microsomal triglyceride transfer protein inhibitor | 0.014 0.012 CID_15897 | ||
| 0.064 | 0.039 | 0.064 | Cannabinoid CB1 receptor agonist | |||
| 0.093 | 0.069 | 0.116 | MAO A inhibitor | 0.116 0.054 CID_15897 | CID_15897 | |
| 0.077 | 0.053 | 0.084 | Nicotinic alpha4beta2 receptor antagonist | 0.084 0.046 CID_15897 | CID_15897 | |
| 0.033 | 0.009 | 0.033 | Lysophosphatidic acid receptor 1 agonist | 0.029 0.012 CID_15897 | ||
| 0.091 | 0.067 | 0.091 | Potassium channel (Voltage-sensitive) activator | 0.087 0.074 CID_15897 | ||
| 0.04 | 0.017 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.042 0.015 CID_15897 | CID_15897 | |
| 0.082 | 0.058 | 0.105 | Glutathione S-transferase inhibitor | 0.105 0.033 CID_15897 | CID_15897 | |
| 0.059 | 0.035 | 0.065 | Human rhinovirus A protease inhibitor | 0.065 0.031 CID_15897 | CID_15897 | |
| 0.037 | 0.014 | 0.037 | Vanilloid 4 antagonist | 0.032 0.023 CID_15897 | ||
| 0.2 | 0.177 | 0.232 | Antithrombotic | 0.232 0.141 CID_15897 | CID_15897 | |
| 0.042 | 0.019 | 0.042 | Delayed rectifier potassium channel blocker | 0.037 0.026 CID_15897 | ||
| 0.075 | 0.052 | 0.075 | Vanilloid 4 agonist | 0.07 0.066 CID_15897 | ||
| 0.03 | 0.008 | 0.03 | Beta 1 adrenoreceptor agonist | |||
| 0.056 | 0.034 | 0.067 | Immunoglobulin Fc receptor antagonist | 0.067 0.014 CID_15897 | CID_15897 | |
| 0.073 | 0.052 | 0.084 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.084 0.029 CID_15897 | CID_15897 | |
| 0.128 | 0.106 | 0.134 | Pregnane X receptor agonist | 0.134 0.088 CID_15897 | CID_15897 | |
| 0.06 | 0.039 | 0.06 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.054 | 0.034 | 0.054 | 5 Hydroxytryptamine 1B agonist | |||
| 0.068 | 0.047 | 0.068 | Alpha adrenoreceptor agonist | |||
| 0.036 | 0.016 | 0.036 | GHS receptor antagonist | |||
| 0.045 | 0.025 | 0.066 | Sphingosine 1-phosphate receptor 1 agonist | 0.066 0.01 CID_15897 | CID_15897 | |
| 0.055 | 0.035 | 0.061 | Elastase inhibitor | 0.061 0.029 CID_15897 | CID_15897 | |
| 0.05 | 0.031 | 0.051 | Glycine transporter inhibitor | 0.051 0.03 CID_15897 | CID_15897 | |
| 0.036 | 0.018 | 0.073 | Dipeptidyl peptidase II inhibitor | 0.073 0.005 CID_15897 | CID_15897 | |
| 0.074 | 0.056 | 0.082 | Analgesic, opioid | 0.082 0.045 CID_15897 | CID_15897 | |
| 0.059 | 0.042 | 0.062 | Cathepsin E inhibitor | 0.062 0.037 CID_15897 | CID_15897 | |
| 0.034 | 0.018 | 0.034 | Peptide deformylase inhibitor | |||
| 0.076 | 0.06 | 0.097 | Chymotrypsin inhibitor | 0.097 0.038 CID_15897 | CID_15897 | |
| 0.048 | 0.032 | 0.051 | Bombesin antagonist | 0.051 0.028 CID_15897 | CID_15897 | |
| 0.033 | 0.018 | 0.056 | Dipeptidyl peptidase I inhibitor | 0.056 0.007 CID_15897 | CID_15897 | |
| 0.03 | 0.015 | 0.035 | Motilin receptor antagonist | 0.035 0.01 CID_15897 | CID_15897 | |
| 0.085 | 0.07 | 0.099 | MAO B inhibitor | 0.099 0.06 CID_15897 | CID_15897 | |
| 0.036 | 0.021 | 0.046 | Growth hormone releasing factor agonist | 0.046 0.015 CID_15897 | CID_15897 | |
| 0.091 | 0.076 | 0.107 | Anabolic | 0.107 0.053 CID_15897 | CID_15897 | |
| 0.024 | 0.01 | 0.024 | Apolipoprotein B inhibitor | |||
| 0.179 | 0.165 | 0.252 | Transcription factor STAT3 inhibitor | 0.252 0.082 CID_15897 | CID_15897 | |
| 0.058 | 0.044 | 0.058 | Ca(v)3.2 blocker | |||
| 0.042 | 0.028 | 0.084 | Sphingosine kinase 1 inhibitor | 0.084 0.005 CID_15897 | CID_15897 | |
| 0.067 | 0.053 | 0.067 | Cannabinoid receptor antagonist | |||
| 0.032 | 0.018 | 0.032 | Liver X receptor beta antagonist | |||
| 0.065 | 0.051 | 0.105 | Potassium channel large-conductance Ca-activated activator | 0.105 0.021 CID_15897 | CID_15897 | |
| 0.03 | 0.016 | 0.03 | LFA antagonist | 0.029 0.018 CID_15897 | ||
| 0.059 | 0.045 | 0.092 | Purinergic P2X1 antagonist | 0.092 0.019 CID_15897 | CID_15897 | |
| 0.056 | 0.043 | 0.064 | Dopamine uptake inhibitor | 0.064 0.035 CID_15897 | CID_15897 | |
| 0.037 | 0.025 | 0.037 | Histone deacetylase 7 inhibitor | |||
| 0.055 | 0.043 | 0.064 | Pregnane X receptor antagonist | 0.064 0.023 CID_15897 | CID_15897 | |
| 0.121 | 0.109 | 0.121 | Insulin secretagoues | 0.117 0.115 CID_15897 | ||
| 0.034 | 0.022 | 0.034 | Calpain 1 inhibitor | |||
| 0.046 | 0.034 | 0.047 | Baculoviral IAP repeat-containing protein inhibitor | 0.047 0.03 CID_15897 | CID_15897 | |
| 0.088 | 0.076 | 0.088 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.044 | 0.032 | 0.057 | Dihydroorotase inhibitor | 0.057 0.018 CID_15897 | CID_15897 | |
| 0.102 | 0.091 | 0.163 | Interleukin 8 antagonist | 0.163 0.026 CID_15897 | CID_15897 | |
| 0.04 | 0.029 | 0.046 | Erythropoietin receptor agonist | 0.046 0.024 CID_15897 | CID_15897 | |
| 0.022 | 0.012 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.022 0.013 CID_15897 | ||
| 0.042 | 0.032 | 0.083 | Glutamate (mGluR4) antagonist | 0.083 0.008 CID_15897 | CID_15897 | |
| 0.038 | 0.029 | 0.038 | Histone deacetylase 9 inhibitor | |||
| 0.058 | 0.048 | 0.058 | Cannabinoid CB1 receptor antagonist | |||
| 0.088 | 0.078 | 0.091 | Electrolyte absorption antagonist | 0.091 0.073 CID_15897 | CID_15897 | |
| 0.037 | 0.028 | 0.042 | Melanocortin 1 antagonist | 0.042 0.023 CID_15897 | CID_15897 | |
| 0.031 | 0.022 | 0.045 | Endothelial nitric-oxide synthase inhibitor | 0.045 0.011 CID_15897 | CID_15897 | |
| 0.044 | 0.036 | 0.044 | Melanocortin antagonist | 0.043 0.038 CID_15897 | ||
| 0.023 | 0.015 | 0.028 | ICAM 1 antagonist | 0.028 0.008 CID_15897 | CID_15897 | |
| 0.068 | 0.06 | 0.15 | Nav1.8 sodium channel blocker | 0.15 0.014 CID_15897 | CID_15897 | |
| 0.089 | 0.081 | 0.141 | GABA C receptor agonist | 0.141 0.038 CID_15897 | CID_15897 | |
| 0.04 | 0.032 | 0.04 | Melanocortin 4 antagonist | 0.037 0.035 CID_15897 | ||
| 0.038 | 0.032 | 0.038 | CC chemokine 3 receptor antagonist | |||
| 0.067 | 0.06 | 0.072 | Peroxisome proliferator-activated receptor gamma antagonist | 0.072 0.049 CID_15897 | CID_15897 | |
| 0.058 | 0.052 | 0.058 | DNA gyrase inhibitor | |||
| 0.041 | 0.036 | 0.062 | Sphingosine 1-phosphate receptor agonist | 0.062 0.015 CID_15897 | CID_15897 | |
| 0.028 | 0.023 | 0.028 | Vasopressin 1A agonist | |||
| 0.014 | 0.009 | 0.015 | Lysophosphatidic acid receptor 3 agonist | 0.015 0.008 CID_15897 | CID_15897 | |
| 0.027 | 0.022 | 0.037 | Thrombin receptor antagonist | 0.037 0.013 CID_15897 | CID_15897 | |
| 0.077 | 0.072 | 0.077 | Histamine H2 receptor antagonist | |||
| 0.018 | 0.013 | 0.018 | Apolipoprotein B-100 inhibitor | |||
| 0.113 | 0.108 | 0.135 | Neurotrophic factor | 0.135 0.074 CID_15897 | CID_15897 | |
| 0.04 | 0.036 | 0.051 | Nerve growth factor antagonist | 0.051 0.017 CID_15897 | CID_15897 | |
| 0.054 | 0.05 | 0.054 | Androgen agonist | 0.053 0.052 CID_15897 | ||
| 0.02 | 0.017 | 0.02 | Acetyl-CoA carboxylase 2 inhibitor | |||
| 0.053 | 0.049 | 0.075 | Carbonic anhydrase stimulant | 0.075 0.028 CID_15897 | CID_15897 | |
| 0.046 | 0.043 | 0.055 | Prolyl endopeptidase inhibitor | 0.055 0.03 CID_15897 | CID_15897 | |
| 0.019 | 0.016 | 0.019 | Integrin alpha4beta7 antagonist | |||
| 0.018 | 0.015 | 0.027 | Growth hormone release promoting | 0.027 0.011 CID_15897 | CID_15897 | |
| 0.079 | 0.077 | 0.14 | Potassium channel (Ca-activated) activator | 0.14 0.031 CID_15897 | CID_15897 | |
| 0.032 | 0.03 | 0.041 | Opioid delta receptor agonist | 0.041 0.018 CID_15897 | CID_15897 | |
| 0.026 | 0.024 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.019 CID_15897 | CID_15897 | |
| 0.066 | 0.064 | 0.066 | Metalloproteinase-9 inhibitor | |||
| 0.041 | 0.04 | 0.041 | Antimetabolite | 0.041 0.039 CID_15897 | ||
| 0.134 | 0.133 | 0.188 | 3C-like protease (Human coronavirus) inhibitor | 0.188 0.059 CID_15897 | CID_15897 | |
| 0.043 | 0.042 | 0.043 | Cannabinoid CB2 receptor antagonist | |||
| 0.058 | 0.058 | 0.07 | Aryl hydrocarbon receptor antagonist | 0.07 0.037 CID_15897 | CID_15897 | |
| 0.045 | 0.045 | 0.108 | Neuropeptide agonist | 0.108 0.025 CID_15897 | CID_15897 | |
| 0.084 | 0.084 | 0.118 | Lanosterol 14 alpha demethylase inhibitor | 0.118 0.032 CID_15897 | CID_15897 | |
| 0.016 | 0.016 | 0.027 | Tryptophan hydroxylase 1 inhibitor | 0.027 0.004 CID_15897 | CID_15897 | |
| 0.037 | 0.038 | 0.047 | Leukocyte elastase inhibitor | 0.047 0.026 CID_15897 | CID_15897 | |
| 0.091 | 0.095 | 0.166 | DOPA decarboxylase inhibitor | 0.166 0.014 CID_15897 | CID_15897 | |
| 0.051 | 0.055 | 0.073 | Bombesin 1 receptor agonist | 0.073 0.029 CID_15897 | CID_15897 | |
| 0.016 | 0.019 | 0.021 | Neurokinin 1 agonist | 0.021 0.014 CID_15897 | CID_15897 | |
| 0.03 | 0.036 | 0.05 | AMPA receptor agonist | 0.05 0.009 CID_15897 | CID_15897 | |
| 0.027 | 0.032 | 0.04 | Calcitonin receptor agonist | 0.04 0.02 CID_15897 | CID_15897 | |
| 0.019 | 0.024 | 0.022 | Bombesin agonist | 0.022 0.016 CID_15897 | CID_15897 | |
| 0.071 | 0.077 | 0.073 | Neuropeptide Y antagonist | 0.073 0.072 CID_15897 | CID_15897 | |
| 0.028 | 0.035 | 0.031 | Carboxypeptidase B inhibitor | 0.031 0.027 CID_15897 | CID_15897 | |
| 0.041 | 0.048 | 0.045 | Ribonucleoside-diphosphate reductase inhibitor | 0.045 0.044 CID_15897 | CID_15897 | |
| 0.047 | 0.054 | 0.061 | Bombesin 3 receptor antagonist | 0.061 0.032 CID_15897 | CID_15897 | |
| 0.012 | 0.02 | 0.02 | Aminopeptidase A inhibitor | 0.02 0.01 CID_15897 | CID_15897 | |
| 0.024 | 0.032 | 0.029 | Trypsin II inhibitor | 0.029 0.022 CID_15897 | CID_15897 | |
| 0.017 | 0.026 | 0.032 | Aminopeptidase P inhibitor | 0.032 0.008 CID_15897 | CID_15897 | |
| 0.015 | 0.024 | 0.018 | Bombesin 3 receptor agonist | 0.018 0.016 CID_15897 | CID_15897 | |
| 0.022 | 0.031 | 0.033 | Calcium-sensing receptor agonist | 0.033 0.011 CID_15897 | CID_15897 | |
| 0.038 | 0.047 | 0.088 | Glutamate (mGluR group III) antagonist | 0.088 0.006 CID_15897 | CID_15897 | |
| 0.081 | 0.09 | 0.108 | Carbonic anhydrase III inhibitor | 0.108 0.054 CID_15897 | CID_15897 | |
| 0.032 | 0.042 | 0.07 | Glutamate (mGluR8) agonist | 0.07 0.005 CID_15897 | CID_15897 | |
| 0.021 | 0.031 | 0.028 | Thyroid hormone agonist | 0.028 0.015 CID_15897 | CID_15897 | |
| 0.06 | 0.07 | 0.067 | Thrombin inhibitor | 0.067 0.058 CID_15897 | CID_15897 | |
| 0.024 | 0.034 | 0.04 | Sirtuin 2 inhibitor | 0.04 0.018 CID_15897 | CID_15897 | |
| 0.041 | 0.051 | 0.055 | Opioid agonist | 0.055 0.034 CID_15897 | CID_15897 | |
| 0.048 | 0.059 | 0.062 | Kallikrein 1 inhibitor | 0.062 0.031 CID_15897 | CID_15897 | |
| 0.036 | 0.048 | 0.063 | Opioid mu receptor agonist | 0.063 0.022 CID_15897 | CID_15897 | |
| 0.187 | 0.199 | 0.242 | Apoptosis antagonist | 0.242 0.136 CID_15897 | CID_15897 | |
| 0.053 | 0.066 | 0.057 | Caspase 9 inhibitor | 0.057 0.055 CID_15897 | CID_15897 | |
| 0.027 | 0.041 | 0.038 | Glutamate (mGluR3) agonist | 0.038 0.012 CID_15897 | CID_15897 | |
| 0.025 | 0.04 | 0.032 | Retinoid X alpha receptor agonist | 0.032 0.027 CID_15897 | CID_15897 | |
| 0.171 | 0.185 | 0.255 | Transcription factor STAT inhibitor | 0.255 0.083 CID_15897 | CID_15897 | |
| 0.042 | 0.056 | 0.071 | Plasminogen activator inhibitor | 0.071 0.031 CID_15897 | CID_15897 | |
| 0.075 | 0.09 | 0.092 | Granulocyte macrophage colony stimulating factor agonist | 0.092 0.047 CID_15897 | CID_15897 | |
| 0.06 | 0.075 | 0.07 | Protein kinase B gamma inhibitor | 0.07 0.058 CID_15897 | CID_15897 | |
| 0.029 | 0.044 | 0.121 | Glutamate (mGluR3) antagonist | 0.121 0.004 CID_15897 | CID_15897 | |
| 0.029 | 0.044 | 0.047 | Toll-Like receptor 2 agonist | 0.047 0.025 CID_15897 | CID_15897 | |
| 0.003 | 0.019 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 CID_15897 | CID_15897 | |
| 0.03 | 0.046 | 0.045 | Dopamine D5 agonist | 0.045 0.021 CID_15897 | CID_15897 | |
| 0.089 | 0.105 | 0.134 | Beta amyloid protein antagonist | 0.134 0.054 CID_15897 | CID_15897 | |
| 0.046 | 0.062 | 0.069 | 5 Hydroxytryptamine uptake inhibitor | 0.069 0.04 CID_15897 | CID_15897 | |
| 0.163 | 0.18 | 0.177 | DNA synthesis inhibitor | 0.177 0.157 CID_15897 | CID_15897 | |
| 0.057 | 0.075 | 0.134 | Glutamate decarboxylase inhibitor | 0.134 0.017 CID_15897 | CID_15897 | |
| 0.034 | 0.053 | 0.056 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.056 0.01 CID_15897 | CID_15897 | |
| 0.018 | 0.037 | 0.026 | Urotensin II agonist | 0.026 0.019 CID_15897 | CID_15897 | |
| 0.047 | 0.066 | 0.093 | Adrenaline uptake inhibitor | 0.093 0.021 CID_15897 | CID_15897 | |
| 0.045 | 0.066 | 0.058 | Dihydroorotate oxidase inhibitor | 0.058 0.032 CID_15897 | CID_15897 | |
| 0.021 | 0.042 | 0.043 | Arginase inhibitor | 0.043 0.019 CID_15897 | CID_15897 | |
| 0.1 | 0.121 | 0.15 | Histone deacetylase SIRT1 inhibitor | 0.15 0.061 CID_15897 | CID_15897 | |
| 0.084 | 0.106 | 0.128 | Mucolytic | 0.128 0.047 CID_15897 | CID_15897 | |
| 0.043 | 0.066 | 0.074 | Glucagon-like peptide 1 agonist | 0.074 0.039 CID_15897 | CID_15897 | |
| 0.14 | 0.164 | 0.194 | Immunostimulant | 0.194 0.124 CID_15897 | CID_15897 | |
| 0.014 | 0.038 | 0.049 | Glutamate (mGluR1a) agonist | 0.049 0.005 CID_15897 | CID_15897 | |
| 0.03 | 0.055 | 0.038 | Neurokinin 2 agonist | 0.038 0.034 CID_15897 | CID_15897 | |
| 0.192 | 0.218 | 0.206 | GABA C receptor rho-3 antagonist | 0.206 0.2 CID_15897 | CID_15897 | |
| 0.072 | 0.098 | 0.169 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.169 0.022 CID_15897 | CID_15897 | |
| 0.074 | 0.1 | 0.1 | 5 Hydroxytryptamine 2 antagonist | 0.1 0.071 CID_15897 | CID_15897 | |
| 0.014 | 0.04 | 0.029 | Methionyl aminopeptidase 2 inhibitor | 0.029 0.014 CID_15897 | CID_15897 | |
| 0.021 | 0.048 | 0.032 | 5 Hydroxytryptamine 6 agonist | 0.032 0.014 CID_15897 | CID_15897 | |
| 0.033 | 0.06 | 0.053 | GABA B receptor antagonist | 0.053 0.017 CID_15897 | CID_15897 | |
| 0.018 | 0.046 | 0.026 | Vanilloid 2 agonist | 0.026 0.016 CID_15897 | CID_15897 | |
| 0.038 | 0.066 | 0.073 | Aminopeptidase microsomal inhibitor | 0.073 0.029 CID_15897 | CID_15897 | |
| 0.044 | 0.074 | 0.055 | 5 Hydroxytryptamine 7 agonist | 0.055 0.04 CID_15897 | CID_15897 | |
| 0.063 | 0.093 | 0.106 | NMDA receptor antagonist | 0.106 0.043 CID_15897 | CID_15897 | |
| 0.031 | 0.062 | 0.039 | Glucagon-like peptide 1 receptor antagonist | 0.039 0.029 CID_15897 | CID_15897 | |
| 0.032 | 0.064 | 0.061 | Kainate receptor agonist | 0.061 0.006 CID_15897 | CID_15897 | |
| 0.053 | 0.086 | 0.113 | Glutamate (mGluR7) antagonist | 0.113 0.005 CID_15897 | CID_15897 | |
| 0.086 | 0.119 | 0.11 | TRPA1 agonist | 0.11 0.072 CID_15897 | CID_15897 | |
| 0.052 | 0.086 | 0.096 | Cathepsin G inhibitor | 0.096 0.035 CID_15897 | CID_15897 | |
| 0.05 | 0.085 | 0.103 | Protein kinase B alpha inhibitor | 0.103 0.029 CID_15897 | CID_15897 | |
| 0.054 | 0.09 | 0.106 | Glutamate dehydrogenase inhibitor | 0.106 0.028 CID_15897 | CID_15897 | |
| 0.031 | 0.067 | 0.064 | Ornithine carbamoyltransferase inhibitor | 0.064 0.029 CID_15897 | CID_15897 | |
| 0.028 | 0.065 | 0.039 | AMPA 4 receptor antagonist | 0.039 0.028 CID_15897 | CID_15897 | |
| 0.08 | 0.117 | 0.129 | Adenylate kinase inhibitor | 0.129 0.037 CID_15897 | CID_15897 | |
| 0.026 | 0.064 | 0.054 | Aminopeptidase N inhibitor | 0.054 0.028 CID_15897 | CID_15897 | |
| 0.02 | 0.058 | 0.031 | Free fatty acid receptor 1 antagonist | 0.031 0.029 CID_15897 | CID_15897 | |
| 0.008 | 0.047 | 0.019 | Dipeptidyl peptidase VIII inhibitor | 0.019 0.008 CID_15897 | CID_15897 | |
| 0.042 | 0.08 | 0.054 | Botulinum neurotoxin type A inhibitor | 0.054 0.048 CID_15897 | CID_15897 | |
| 0.054 | 0.093 | 0.063 | Calcium channel P-type blocker | 0.063 0.046 CID_15897 | CID_15897 | |
| 0.079 | 0.118 | 0.137 | Nav1.4 sodium channel blocker | 0.137 0.04 CID_15897 | CID_15897 | |
| 0.029 | 0.069 | 0.054 | Phenylethanolamine N methyltransferase inhibitor | 0.054 0.011 CID_15897 | CID_15897 | |
| 0.041 | 0.081 | 0.06 | Neutrophil collagenase inhibitor | 0.06 0.051 CID_15897 | CID_15897 | |
| 0.085 | 0.125 | 0.119 | Photosensitizer | 0.119 0.058 CID_15897 | CID_15897 | |
| 0.037 | 0.079 | 0.046 | Cytokine production stimulant | 0.046 0.043 CID_15897 | CID_15897 | |
| 0.019 | 0.061 | 0.037 | Complement C3a chemotactic receptor antagonist | 0.037 0.034 CID_15897 | CID_15897 | |
| 0.209 | 0.252 | 0.269 | MAP kinase kinase 6 inhibitor | 0.269 0.168 CID_15897 | CID_15897 | |
| 0.028 | 0.071 | 0.039 | Nicotinic receptor alpha3 subunit antagonist | 0.039 0.037 CID_15897 | CID_15897 | |
| 0.008 | 0.052 | 0.024 | Dipeptidyl peptidase IX inhibitor | 0.024 0.007 CID_15897 | CID_15897 | |
| 0.026 | 0.069 | 0.057 | NMDA 2A receptor antagonist | 0.057 0.032 CID_15897 | CID_15897 | |
| 0.025 | 0.069 | 0.04 | Growth hormone release inhibitor | 0.04 0.031 CID_15897 | CID_15897 | |
| 0.066 | 0.111 | 0.119 | Alcohol dehydrogenase inhibitor | 0.119 0.035 CID_15897 | CID_15897 | |
| 0.085 | 0.131 | 0.119 | Cyclooxygenase 3 inhibitor | 0.119 0.078 CID_15897 | CID_15897 | |
| 0.111 | 0.157 | 0.153 | Melanin inhibitor | 0.153 0.077 CID_15897 | CID_15897 | |
| 0.027 | 0.075 | 0.033 | Adenosine uptake inhibitor | 0.033 0.031 CID_15897 | CID_15897 | |
| 0.175 | 0.223 | 0.278 | Immunosuppressant | 0.278 0.129 CID_15897 | CID_15897 | |
| 0.033 | 0.082 | 0.088 | Argininosuccinate synthase inhibitor | 0.088 0.022 CID_15897 | CID_15897 | |
| 0.019 | 0.068 | 0.042 | Somatostatin 1 antagonist | 0.042 0.025 CID_15897 | CID_15897 | |
| 0.004 | 0.055 | 0.014 | Glutamate (mGluR6) agonist | 0.014 0.007 CID_15897 | CID_15897 | |
| 0.028 | 0.079 | 0.073 | Dopamine transporter inhibitor | 0.073 0.019 CID_15897 | CID_15897 | |
| 0.121 | 0.172 | 0.149 | Aldehyde oxidase inhibitor | 0.149 0.14 CID_15897 | CID_15897 | |
| 0.069 | 0.12 | 0.156 | Ferrochelatase inhibitor | 0.156 0.035 CID_15897 | CID_15897 | |
| 0.018 | 0.072 | 0.071 | Kainate receptor antagonist | 0.071 0.012 CID_15897 | CID_15897 | |
| 0.082 | 0.136 | 0.113 | Aldehyde dehydrogenase inhibitor | 0.113 0.079 CID_15897 | CID_15897 | |
| 0.005 | 0.059 | 0.03 | Kainate receptor 1 antagonist | 0.03 0.01 CID_15897 | CID_15897 | |
| 0.014 | 0.069 | 0.052 | Kainate receptor 2 antagonist | 0.052 0.015 CID_15897 | CID_15897 | |
| 0.034 | 0.09 | 0.074 | NMDA receptor glycine site agonist | 0.074 0.033 CID_15897 | CID_15897 | |
| 0.111 | 0.168 | 0.224 | Interleukin antagonist | 0.224 0.072 CID_15897 | CID_15897 | |
| 0.048 | 0.105 | 0.058 | Trypsin inhibitor | 0.058 0.053 CID_15897 | CID_15897 | |
| 0.066 | 0.126 | 0.089 | Polo-like kinase-1 inhibitor | 0.089 0.063 CID_15897 | CID_15897 | |
| 0.036 | 0.097 | 0.104 | Protein kinase C iota inhibitor | 0.104 0.018 CID_15897 | CID_15897 | |
| 0.052 | 0.114 | 0.097 | Glycine receptor agonist | 0.097 0.023 CID_15897 | CID_15897 | |
| 0.139 | 0.202 | 0.16 | MAP kinase kinase 5 inhibitor | 0.16 0.116 CID_15897 | CID_15897 | |
| 0.042 | 0.105 | 0.065 | Porphobilinogen synthase inhibitor | 0.065 0.061 CID_15897 | CID_15897 | |
| 0.053 | 0.117 | 0.081 | Histamine N-methyltransferase inhibitor | 0.081 0.066 CID_15897 | CID_15897 | |
| 0.015 | 0.08 | 0.038 | Fumarate hydratase inhibitor | 0.038 0.02 CID_15897 | CID_15897 | |
| 0.058 | 0.122 | 0.098 | Urease inhibitor | 0.098 0.069 CID_15897 | CID_15897 | |
| 0.022 | 0.088 | 0.055 | Adenosine deaminase inhibitor | 0.055 0.025 CID_15897 | CID_15897 | |
| 0.042 | 0.108 | 0.062 | Nav1.7 sodium channel blocker | 0.062 0.054 CID_15897 | CID_15897 | |
| 0.174 | 0.24 | 0.298 | Interleukin 2 agonist | 0.298 0.075 CID_15897 | CID_15897 | |
| 0.09 | 0.157 | 0.157 | Sphingosine 1-phosphate receptor 4 antagonist | 0.157 0.028 CID_15897 | CID_15897 | |
| 0.04 | 0.107 | 0.123 | Histidine decarboxylase inhibitor | 0.123 0.025 CID_15897 | CID_15897 | |
| 0.021 | 0.09 | 0.057 | Glutamate (mGluR group I) agonist | 0.057 0.025 CID_15897 | CID_15897 | |
| 0.086 | 0.156 | 0.179 | Peroxidase inhibitor | 0.179 0.066 CID_15897 | CID_15897 | |
| 0.031 | 0.102 | 0.045 | Histamine H4 receptor antagonist | 0.045 0.042 CID_15897 | CID_15897 | |
| 0.117 | 0.189 | 0.161 | Focal adhesion kinase 2 inhibitor | 0.161 0.114 CID_15897 | CID_15897 | |
| 0.039 | 0.112 | 0.116 | Glutamate receptor agonist | 0.116 0.028 CID_15897 | CID_15897 | |
| 0.031 | 0.104 | 0.055 | Aconitate hydratase inhibitor | 0.055 0.032 CID_15897 | CID_15897 | |
| 0.032 | 0.107 | 0.399 | 5 Hydroxytryptamine agonist | 0.399 0.005 CID_15897 | CID_15897 | |
| 0.167 | 0.246 | 0.225 | MAP kinase kinase 3 inhibitor | 0.225 0.064 CID_15897 | CID_15897 | |
| 0.132 | 0.212 | 0.169 | Hypoglycemic | 0.169 0.148 CID_15897 | CID_15897 | |
| 0.168 | 0.249 | 0.294 | Histamine release inhibitor | 0.294 0.127 CID_15897 | CID_15897 | |
| 0.046 | 0.128 | 0.094 | GABA aminotransferase inhibitor | 0.094 0.032 CID_15897 | CID_15897 | |
| 0.103 | 0.186 | 0.142 | Interferon gamma antagonist | 0.142 0.09 CID_15897 | CID_15897 | |
| 0.062 | 0.15 | 0.091 | Bile acid receptor antagonist | 0.091 0.071 CID_15897 | CID_15897 | |
| 0.056 | 0.147 | 0.099 | Expectorant | 0.099 0.07 CID_15897 | CID_15897 | |
| 0.114 | 0.206 | 0.15 | Phospholipase C inhibitor | 0.15 0.105 CID_15897 | CID_15897 | |
| 0.021 | 0.115 | 0.041 | NMDA receptor subunit 3B antagonist | 0.041 0.034 CID_15897 | CID_15897 | |
| 0.103 | 0.197 | 0.149 | CF transmembrane conductance regulator agonist | 0.149 0.078 CID_15897 | CID_15897 | |
| 0.023 | 0.118 | 0.046 | Glutamate (mGluR8) antagonist | 0.046 0.01 CID_15897 | CID_15897 | |
| 0.011 | 0.113 | 0.221 | 5 Hydroxytryptamine 2C agonist | 0.221 0.004 CID_15897 | CID_15897 | |
| 0.046 | 0.149 | 0.085 | Glutamate (mGluR6) antagonist | 0.085 0.019 CID_15897 | CID_15897 | |
| 0.027 | 0.13 | 0.071 | Carbamoyl phosphate synthetase inhibitor | 0.071 0.034 CID_15897 | CID_15897 | |
| 0.051 | 0.155 | 0.117 | HIV-1 integrase (Overall Integration) inhibitor | 0.117 0.042 CID_15897 | CID_15897 | |
| 0.134 | 0.243 | 0.184 | RNA-directed DNA polymerase inhibitor | 0.184 0.125 CID_15897 | CID_15897 | |
| 0.052 | 0.163 | 0.071 | GABA B receptor agonist | 0.071 0.066 CID_15897 | CID_15897 | |
| 0.168 | 0.28 | 0.195 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.195 0.179 CID_15897 | CID_15897 | |
| 0.064 | 0.176 | 0.099 | Interleukin 12 antagonist | 0.099 0.055 CID_15897 | CID_15897 | |
| 0.084 | 0.197 | 0.127 | Arachidonic acid antagonist | 0.127 0.117 CID_15897 | CID_15897 | |
| 0.019 | 0.135 | 0.059 | NMDA 2C receptor antagonist | 0.059 0.047 CID_15897 | CID_15897 | |
| 0.022 | 0.145 | 0.073 | NMDA 2 receptor antagonist | 0.073 0.049 CID_15897 | CID_15897 | |
| 0.024 | 0.148 | 0.068 | Phosphofructokinase-1 inhibitor | 0.068 0.049 CID_15897 | CID_15897 | |
| 0.057 | 0.181 | 0.111 | Histone deacetylase class III inhibitor | 0.111 0.078 CID_15897 | CID_15897 | |
| 0.012 | 0.141 | 0.042 | Urokinase inhibitor | 0.042 0.037 CID_15897 | CID_15897 | |
| 0.013 | 0.144 | 0.052 | Glutamate (mGluR group II) antagonist | 0.052 0.014 CID_15897 | CID_15897 | |
| 0.076 | 0.214 | 0.127 | Cell wall synthesis inhibitor | 0.127 0.09 CID_15897 | CID_15897 | |
| 0.08 | 0.219 | 0.129 | LIM domain kinase 1 inhibitor | 0.129 0.122 CID_15897 | CID_15897 | |
| 0.008 | 0.151 | 0.031 | Glutamate (mGluR2) antagonist | 0.031 0.018 CID_15897 | CID_15897 | |
| 0.088 | 0.233 | 0.168 | Interleukin 6 antagonist | 0.168 0.066 CID_15897 | CID_15897 | |
| 0.008 | 0.154 | 0.021 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 CID_15897 | CID_15897 | |
| 0.078 | 0.229 | 0.102 | Sphingosine 1-phosphate receptor 2 agonist | 0.102 0.095 CID_15897 | CID_15897 | |
| 0.066 | 0.218 | 0.23 | Angiogenesis stimulant | 0.23 0.079 CID_15897 | CID_15897 | |
| 0.092 | 0.265 | 0.141 | Succinate dehydrogenase inhibitor | 0.141 0.131 CID_15897 | CID_15897 | |
| 0.089 | 0.263 | 0.241 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.241 0.065 CID_15897 | CID_15897 | |
| 0.063 | 0.27 | 0.149 | Protein kinase (CK1) gamma 3 inhibitor | 0.149 0.091 CID_15897 | CID_15897 | |
| 0.039 | 0.246 | 0.102 | Cystathionine beta-synthase inhibitor | 0.102 0.074 CID_15897 | CID_15897 | |
| 0.071 | 0.312 | 0.186 | Non-steroidal antiinflammatory agent | 0.186 0.083 CID_15897 | CID_15897 | |
| 0.037 | 0.287 | 0.083 | Factor XII inhibitor | 0.083 0.06 CID_15897 | CID_15897 | |
| 0.028 | 0.358 | 0.123 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.123 0.099 CID_15897 | CID_15897 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |